Proteomics

Dataset Information

0

C4PR_LIV: N-terminomic analysis of SARS-CoV-2-infected Vero E6 cells treated with protease inhibitors (Enriched – Variable Search)


ABSTRACT: Many events in viral infection are regulated through post-translational modification. In the case of positive-sense RNA viruses such as SARS-CoV-2 which encodes two viral proteases, proteolytic cleavage of both viral and cellular proteins is crucial for productive viral infection. In this work we study proteolysis in the context of SARS-CoV-2 infection of Vero E6 cells, treated with calpeptin or camostat at 12h post-infection and harvested at 24h post-infection. Our goal was Neo-N-termini and lysine residues were labelled at the protein level with TMTpro reagents prior to tryptic digestion. For unenriched samples, the trypsin-digested material was then fractionated offline, and analysed by LC-MS/MS for the study of total protein abundance over the infection timecourse. For enriched samples, unblocked neo-N-termini generated by tryptic digested were labelled with undecanal and depleted, yielding a sample enriched for blocked neo-N-termini (TMTpro, N-terminal acetylation, and pyroGlu). The enriched samples were similarly fractionated offline and analysed by LC-MS/MS.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Cercopithecus Aethiops (green Monkey) (grivet)

TISSUE(S): Permanent Cell Line Cell, Cell Culture

DISEASE(S): Severe Acute Respiratory Syndrome

SUBMITTER: Ed Emmott  

LAB HEAD: Edward Emmott

PROVIDER: PXD023540 | Pride | 2021-07-30

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
A44522_VB294905.PDF Pdf
EE081020_SARS2Inhib_Nterm_A.raw Raw
EE081020_SARS2Inhib_Nterm_B.raw Raw
EE081020_SARS2Inhib_Nterm_C.raw Raw
EE081020_SARS2Inhib_Nterm_D.raw Raw
Items per page:
1 - 5 of 27

Similar Datasets

2021-07-29 | PXD021402 | Pride
2021-07-29 | PXD021153 | Pride
2021-07-29 | PXD021152 | Pride
2021-07-29 | PXD023538 | Pride
2021-07-29 | PXD021403 | Pride
2021-07-30 | PXD023539 | Pride
2021-07-29 | PXD021154 | Pride
2021-07-29 | PXD021145 | Pride
2024-05-02 | PXD047261 | Pride
2023-10-18 | PXD039426 | Pride